FIELD: medicine.
SUBSTANCE: invention relates to medicine and can be used for determination of selection of heparin application for prevention of thrombotic complications. For this purpose level of soluble fibrin-monomer complexes is determined in blood plasma by means of ortho-phenantroline test. If its value is lower than 15.0 mg/100 ml transdermal way of heparin introduction is used. If the value is higher than 15.0 mg/100 ml parenteral way of heparin introduction is used.
EFFECT: method ensures efficient prevention of thrombotic complications due to selection of way of heparin introduction depending on degree of intravascular thrombus-formation.
4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREVENTING THROMBOTIC COMPLICATIONS OF PREGNANCY IN WOMEN WITH NON-DIFFERENTIATED FORMS OF MESENCHYMAL DYSPLASIA | 2012 |
|
RU2514045C2 |
| METHOD FOR DETERMINING HIGH THROMBOGENIC RISK IN PREGNANCY FOR HEPARIN PREVENTION | 2014 |
|
RU2564945C1 |
| METHOD FOR DETECTING HYPERCOAGULATION AND INTRAVASCULAR COAGULATION ACTIVATION IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA IN MANIFESTATION | 2012 |
|
RU2497127C1 |
| METHOD OF DETECTING THROMBINEMIA IN LARGE JOINT REPLACEMENT | 2009 |
|
RU2423697C2 |
| METHOD FOR PREDICTION OF RISK OF MALIGNANT GROWTHS IN FEMALE GENITAL ORGANS AND MAMMARY GLANDS | 2014 |
|
RU2578459C1 |
| METHOD FOR DEFINING EARLY PERIOD CRITERIA FOR DETECTING HYPERCOAGULATION SINGS IN TREATING ACUTE LEUCOSIS PATIENTS | 2002 |
|
RU2227301C2 |
| METHOD FOR PREVENTING CHRONIC LEAD COAGULOPATHY IN EXPERIMENTAL ANIMALS | 2019 |
|
RU2706386C1 |
| METHOD FOR PREVENTION OF CHRONIC SUBLEME COAGULOPATHY IN RATS IN EXPERIMENT | 2022 |
|
RU2788609C1 |
| METHOD FOR PREVENTING CHRONIC MOLYBDENUM COAGULOPATHY | 2020 |
|
RU2739690C1 |
| METHOD FOR PREVENTION OF TOXIC COAGULOPATHY IN RATS | 2022 |
|
RU2794030C1 |
